108 related articles for article (PubMed ID: 33745745)
21. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
22. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
23. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
24. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
Jiang YP; Shen Y; Sun N; Wang H
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
[TBL] [Abstract][Full Text] [Related]
25. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
26. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
[TBL] [Abstract][Full Text] [Related]
27. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
Wasserman JD; Sabbaghian N; Fahiminiya S; Chami R; Mete O; Acker M; Wu MK; Shlien A; de Kock L; Foulkes WD
J Clin Endocrinol Metab; 2018 May; 103(5):2009-2015. PubMed ID: 29474644
[TBL] [Abstract][Full Text] [Related]
28. Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.
Lin XD; Wu YP; Chen SH; Sun XL; Ke ZB; Chen DN; Li XD; Lin YZ; Wei Y; Zheng QS; Xu N; Xue XY
Mol Genet Genomic Med; 2020 Jan; 8(1):e1032. PubMed ID: 31701684
[TBL] [Abstract][Full Text] [Related]
29. Over-Expression of miR-21 and Lower PTEN Levels in Wilms' Tumor with Aggressive Behavior.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
Tohoku J Exp Med; 2017 May; 242(1):43-52. PubMed ID: 28529243
[TBL] [Abstract][Full Text] [Related]
30. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
31. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour.
Tang F; Lu Z; Wang J; Li Z; Wu W; Duan H; He Z
BMC Med Genomics; 2019 Dec; 12(1):194. PubMed ID: 31842887
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic findings in Wilms' tumour: a single institute study.
MdZin R; Murch A; Charles A
Pathology; 2010 Dec; 42(7):643-9. PubMed ID: 21080873
[TBL] [Abstract][Full Text] [Related]
33. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
[TBL] [Abstract][Full Text] [Related]
34. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
35. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
36. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
37. Evolution of Renal Cysts to Anaplastic Sarcoma of Kidney in a Child With DICER1 Syndrome.
Wu MK; Goudie C; Druker H; Thorner P; Traubici J; Grant R; Albrecht S; Weber E; Charles A; Priest JR; Fabian MR; Foulkes WD
Pediatr Blood Cancer; 2016 Jul; 63(7):1272-5. PubMed ID: 26928971
[TBL] [Abstract][Full Text] [Related]
38. Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations.
Cajaiba MM; Khanna G; Smith EA; Gellert L; Chi YY; Mullen EA; Hill DA; Geller JI; Dome JS; Perlman EJ
Hum Pathol; 2016 Feb; 48():81-7. PubMed ID: 26772403
[TBL] [Abstract][Full Text] [Related]
39. Tumor progression in DICER1-mutated cystic nephroma-witnessing the genesis of anaplastic sarcoma of the kidney.
Wu MK; Cotter MB; Pears J; McDermott MB; Fabian MR; Foulkes WD; O'Sullivan MJ
Hum Pathol; 2016 Jul; 53():114-20. PubMed ID: 27036314
[TBL] [Abstract][Full Text] [Related]
40. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
